Effect of Nutritional Supplementation on Nutritional Status & Rehospitalization in Malnourished Elderly Patients
The Effect of 12 Weeks of Nutritional Supplementation on Nutritional Intake and Status in Older Outpatients With Malnutrition Risk
1 other identifier
interventional
105
1 country
2
Brief Summary
The primary outcome is the mean difference in energy and protein as well as a selection of micronutrients (calcium, vitamin D, and Vitamin B12) after 12 weeks of intervention between standard care plus nutritional supplementation vs standard care. The secondary outcomes are body weight, nutritional status, body composition, physical performance, vitamin D level, and nonelective hospitalization The Study Hypothesize: The hypothesize that outpatients who receive nutrient-dense drinks (NDD) will have increased body weight, better nutritional status, better body composition, higher vitamin D level, better physical performance and reduced non-elective hospitalization than those receiving standard care after 12 weeks of intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2022
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 9, 2022
CompletedStudy Start
First participant enrolled
July 15, 2022
CompletedFirst Posted
Study publicly available on registry
October 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2023
CompletedAugust 27, 2024
August 1, 2024
1.3 years
March 9, 2022
August 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Changes of Energy in Kilocalories
Dietary intake will be measured using 3-day dietary food records, 2 weekdays and 1 weekend day)
at baseline and week 12
Changes in Protein intake in grams
Dietary intake will be measured using 3-day dietary food records, 2 weekdays and 1 weekend day)
at baseline and week 12
Changes in Fat intake in grams
Dietary intake will be measured using 3-day dietary food records, 2 weekdays and 1 weekend day)
at baseline and week 12
Changes in carbohydrate intake in grams
Dietary intake will be measured using 3-day dietary food records, 2 weekdays and 1 weekend day)
at baseline and week 12
Changes in micronutrients intake in micrograms
Dietary intake will be measured using 3-day dietary food records, 2 weekdays and 1 weekend day)
at baseline and week 12
Secondary Outcomes (9)
Changes of Mini Nutritional Status Score
at screening (Week 0) and week 12
Changes of Vitamin D level
Screening (Week 0) and week 12
Changes of Body Weight
Screening (week 0) and Week 12
Changes of Skeletal Muscle Mass
Screening (Week 0) and week 12
Changes of Short Physical Performance Battery Score
Screening (Week 0) and week 12
- +4 more secondary outcomes
Other Outcomes (1)
Balance Test
Screening (Week 0) and week 12
Study Arms (2)
Nutrient Dense Drink
EXPERIMENTALExperimental: Nutrient-dense drink Nutrient-dense drink on top of standard care * 200 kcal * 15 grams of (whey) protein, 8 grams of fat, and 17 grams of carbohydrates including only 0.2 g lactose * 400 IU vitamin D, 250 mg Ca, 10-20 % of the other vitamins/minerals Servings : • 100 ml water for dissolving 46 g of the served powder
Standard Care
NO INTERVENTIONStandard care comprising: Standard care only will be provided nutritional counseling to achieve a better nutritional state
Interventions
a nutrient-dense drink developed by FrieslandCampina in line with the European Society for Clinical Nutrition and Metabolism guidelines for the dietary management of older malnourished patients
Eligibility Criteria
You may qualify if:
- older patients (60-years or older)
- Malnourished or at risk of malnourished (based on Mini Nutritional Assessment score)
You may not qualify if:
- Impaired kidney function (eGFR less than 30 ml/min/1.73 m2)
- Unwillingness to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Indonesia Universitylead
- Wageningen Universitycollaborator
- FrieslandCampinacollaborator
Study Sites (2)
Cipto Mangunkusumo National Hospital
Jakarta, 10430, Indonesia
Comprehensive Geriatric Clinic, Cipto Mangunkusumo Hospital
Jakarta, Indonesia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Prof. Siti Setiati, MD (Internist Geriatrician),PhD
Indonesia University
- STUDY CHAIR
Prof.Dr.Ing. Lisette CPGM de Groot, PhD
Wageningen University the Netherlands
- STUDY DIRECTOR
Esthika Dewiasty, MD (Internist Geriatrician), MSc
Universitas Indonesia, PhD candidate at Wageningen University
- STUDY DIRECTOR
Sjors Verlaan, PhD
FrieslandCampina
- STUDY DIRECTOR
Rahmi Istanti, BSc, MPH
Indonesia University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcomes assessment will be performed by blinded raters.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Geriatric Medicine
Study Record Dates
First Submitted
March 9, 2022
First Posted
October 5, 2023
Study Start
July 15, 2022
Primary Completion
October 15, 2023
Study Completion
October 15, 2023
Last Updated
August 27, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share
All findings of this study will be published in an international open-access journal. Please contact us if any researchers need our individual participant data.